Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

Objective: This study aims to investigate the efficacy and safety of prostate-specific membrane antigen (PSMA) radiolabeled with copper-64 (64Cu) using the bifunctional chelating agents (BFCAs) NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) and DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetr...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nuclear Medicine & Molecular Imaging Vol. 52; no. 8; pp. 2792 - 2804
Autores principales: Liu, Huanhuan, Zhang, Xiaojun, Zhang, Jingfeng, Pan, Yue, Wen, Hui, Xu, Xiaodan, Wu, Shina, Wang, Yuan, Zhang, Cong, Ma, Guangyu, Liu, Yachao, Wang, Ruimin, Zhang, Jinming
Formato: Journal Article
Publicado: Springer Nature Jul2025
Acceso en línea:Ver este registro en EBSCOhost